Bavarian Nordic AS operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other
pharmaceutical manufacturers in North America:
sales of $82.27 million
Ultragenyx Pharmaceutical Inc
of which 100%
was Pharmaceutical Preparation), and
Bavarian Nordic AS reported sales of $99.19 million
December of 2019.
increase of 25.3%
versus 2018, when the company's sales were $79.13 million.
Despite this increase, sales are still
below the level achieved in 2017, when Bavarian Nordic AS
reported sales of $209.82 million.